Lower Risk of ALS Seen for Men With High Levels of Physical Activity, Fitness
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 26, 2024 -- For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS), according to a study published online June 27 in Neurology.
Anders M. Vaage, M.D., from Akershus University Hospital in Lørenskog Norway, and colleagues examined the relationship between indicators of physical activity and fitness and long-term ALS risk using data from a large Norwegian cardiovascular health survey. The risk of ALS was assessed according to levels of self-reported physical activity in three categories: sedentary; minimum four hours/week of walking or cycling; and minimum four hours/week of recreational sports or hard training.
The researchers found that 504 of the 373,696 study participants (mean age, 4.9 years) developed ALS during a mean follow-up of 27.2 years. The hazard ratio was 0.71 for the highest versus the lowest level of physical activity. In the total sample, there were no clear associations seen between resting heart rate and ALS. In men, the hazard ratios of ALS were 0.71 and 0.59 for those reporting moderate and high levels of physical activity, respectively, versus low levels. The risk of ALS was reduced for men with resting heart rate in the lowest quartile versus the second highest quartile (hazard ratio, 0.68). No association was seen for self-reported levels of physical activity or resting heart rate with ALS risk among women.
"Moderate to high levels of physical activity and fitness in middle age do not increase ALS risk. Rather, it may be protective against the disease, but only in men," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-27 07:15
Read more
- UCB Receives U.S. FDA Approval for 320 mg Single-Injection Device Presentations of Bimzelx (bimekizumab-bkzx)
- 3 Years of Med School Might Be Enough to Produce Quality Doctors
- Preventing, Treating Sports Injuries in Kids: A Guide
- What You Need to Know About FluMist, the Nasal Flu Vaccine
- McDonald's Quarter Pounder Beef Patties Not Source of E. Coli Contamination
- Virtual Yoga Classes Aid Chronic Low Back Pain
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions